For the best experience, use the Insights app.
Get the appGetA study published in the European Medical Journal reports that the combination of pembrolizumab and olaparib delays the progression of ovarian cancer. This treatment approach shows promise in improving outcomes for patients by slowing disease advancement.
European Medical Journal·
Robotics startup RobCo has achieved a valuation of $1 billion, marking a significant milestone for the company. This valuation reflects investor confidence in RobCo's technology and growth potential in the robotics sector. The milestone highlights the increasing interest and investment in robotics innovation.
WSJ·
PoliticsFollowing Justice Ujjwal Bhuiyan's comments criticizing the denial of voting rights, Congress has firmly demanded the immediate resignation of Dyanesh Kumar. Justice Bhuiyan highlighted the arbitrary nature of processes that prevent voting, stating no excuse justifies such actions. He also pointed out the Supreme Court's inaction despite 90 million voters losing their rights in Bengal.
Navbharat Times·
The International Renewable Energy Agency (IRENA) has released the annual progress report for the SIDS Lighthouses Initiative covering 2025–2026. The report details advancements in renewable energy projects aimed at supporting Small Island Developing States (SIDS) in their sustainable energy transitions. It highlights key achievements, challenges, and future plans to accelerate clean energy adoption in these vulnerable regions.
International Renewable Energy Agency (IRENA)·
HealthA cross-sectional study in Japan examined oral health and functional outcomes in adults with hemophilia, stratifying participants by HIV status. The research aimed to explore differences in oral health conditions and related functional impacts among hemophilia patients with and without HIV, providing insights into their specific healthcare needs.
Nature·
Students from the 2025 batch of the MSc Social Data Science and Policy program at Amrita Vishwa Vidyapeetham undertook a field immersion in rural Uttarakhand. This practical experience allowed them to engage directly with local communities, applying their academic knowledge to real-world social and policy issues in the region.
Amrita Vishwa Vidyapeetham··Uttarakhand
European Medical Journal·
A study published in the European Medical Journal reports that the combination of pembrolizumab and olaparib delays the progression of ovarian cancer. This treatment approach shows promise in improving outcomes for patients by slowing disease advancement.
Tip: use ↑ / ↓ (or j / k) to move between stories.
